• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    20.38 Down 0.24(1.16%) May 22, 3:59PM EDT
    |After Hours : 20.38 0.00 (0.00%) May 22, 4:25PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 158,373   48,546   -  
    Cost of Revenue14,370  5,019   -  
    Gross Profit 144,003   43,527   -  
    Operating Expenses
    Research Development37,985  29,788  25,164  
    Selling General and Administrative132,715  76,082  34,077  
    Non Recurring5  4  1,366  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (26,702) (62,347) (60,607)
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,847)58  (721)
    Earnings Before Interest And Taxes(28,549)(62,289)(61,328)
    Interest Expense9,937  722  937  
    Income Before Tax(38,486)(63,011)(62,265)
    Income Tax Expense899  347   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(39,385)(63,358)(62,265)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (39,385) (63,358) (62,265)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (39,385) (63,358) (62,265)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.